- Home
- MMD vs AMRN Comparison
MMD vs AMRN Comparison
Compare MMD & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMD | AMRN |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.7M | 339.8M |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | MMD | AMRN |
|---|---|---|
| Price | $15.13 | $15.62 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 74.7K | ★ 97.5K |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | ★ 4.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $226,733,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.30 | $7.08 |
| 52 Week High | $17.67 | $20.90 |
Technical Indicators
Market Signals| Indicator | MMD | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 58.40 | 56.95 |
| Support Level | $15.15 | $14.50 |
| Resistance Level | $15.28 | $16.80 |
| Average True Range (ATR) | 0.09 | 0.81 |
| MACD | 0.02 | 0.18 |
| Stochastic Oscillator | 69.23 | 65.62 |
Price Performance
Historical ComparisonAbout MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.